Disease Management Update

Chan BSW, Tsang MW, Lee VWY, et al. Cost of type 2 diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Therap 2007; 45(8): 455–68 Cohen J, Stolk E, Niezen M. The increasingly complex fourth hurdle for pharmaceuticals. Pharmacoeconomics 2007; 25(9): 727–34 Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics 2007; 25(9): 713–26 Goldie SJ, Kim JJ, Kobus K, et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 2007; 25(33): 6257–70 Vallano A, Malouf J, Payrulet P, Catalan Research Group for the Study of Pain in the Hospital. Analgesic use and pain in the hospital settings. Euro J Clin Pharmacol 2007; 63(6): 619–26 Schaefer K, Hansen AO, Maerkedahl H, et al. Changing GPs’ prescription patterns through guidelines and feedback: intervention study. Pharmacoepidemiol Drug Saf 2007; 16(6): 695–704 Omar AR, Suppiah N, Chai P, et al. Efficacy of community-based multidisciplinary disease management of chronic heart failure. Singapore Med J 2007; 48(6): 528–31 Hoshi S-L, Kondo M, Honda Y, et al. Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan. Vaccine 2007; 25(35): 6511–21 Schousboe JT, Taylor BC, Fink HA, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 2007; 298(6): 629–37 Straka RJ, Mamdani M, Damen J, et al. Economic impacts attributable to the early clinical benefit of atorvastatin therapy: a US managed care perspective. Curr Med Res Opin 2007; 23(7): 1517–29 Brumley R, Enguidanos S, Jamison P, et al. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Ger Soc 2007; 55(7): 993–1000 Garcia-Monco JC, Foncea N, Bilbao A, et al. Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients. Cephalalgia 2007; 27(8): 920–8 Frank RG. Regulation of follow-on biologies. N Eng J Med 2007; 357(9): 841–8 Smith TW, Cherry SB, Tang SSK, et al. Clinical and economic consequences of a single-pill combination of amlodipine/atorvastatin compared with a two-pill regimen in hypertensive patients with additional cardiovascular risk factors [abstract p4800 plus poster]. Eur Heart J 2007; 28 (Suppl.): 857 Lindgren P, Buxton M, Kahan T, et al. Amlodipine + atorvastatin is cost-effective compared to atenolol + atorvastatin, amlodipine or atenolol alone: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) [abstract plus poster]. Eur Heart J 2007; 28 (Suppl.): 857 Altice FL, Smith-Rohrberg Maru D, Brace RD, et al. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drag users: a prospective, randomized, controlled trial. Clin Infect Dis 2007; 45(6): 770–8 Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA 2007; 298(2): 211–24 Campbell HM, Boardman KD, Dodd MA, et al. Pharmacoeconomic analysis of angi-otensin-converting enzyme inhibitors in type 2 diabetes: a Markov model. Ann Pharmacother 2007; 41(7–8): 1101–10 Hellinger FJ. The changing pattern of hospital care for persons living with HIV: 2000 through 2004. J Acquir Immune Defic Syndr 2007; 45(2): 239–46